BRPI0518636B8 - “kits não-radioativo liofilizado de multi-doses, e, processo para a preparação de múltiplas doses de paciente unitárias do radiofarmacêutico tetrofosmina- 99m tc" - Google Patents

“kits não-radioativo liofilizado de multi-doses, e, processo para a preparação de múltiplas doses de paciente unitárias do radiofarmacêutico tetrofosmina- 99m tc"

Info

Publication number
BRPI0518636B8
BRPI0518636B8 BRPI0518636A BRPI0518636A BRPI0518636B8 BR PI0518636 B8 BRPI0518636 B8 BR PI0518636B8 BR PI0518636 A BRPI0518636 A BR PI0518636A BR PI0518636 A BRPI0518636 A BR PI0518636A BR PI0518636 B8 BRPI0518636 B8 BR PI0518636B8
Authority
BR
Brazil
Prior art keywords
tetrofosmin
preparation
radiopharmaceutical
multiple unit
radioactive
Prior art date
Application number
BRPI0518636A
Other languages
English (en)
Inventor
Karin Martinussen Grethe
Stensrud Gry
Kristian Hjelstuen Ole
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of BRPI0518636A2 publication Critical patent/BRPI0518636A2/pt
Publication of BRPI0518636B1 publication Critical patent/BRPI0518636B1/pt
Publication of BRPI0518636B8 publication Critical patent/BRPI0518636B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Lock And Its Accessories (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Devices For Supply Of Signal Current (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
  • Noodles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

kits não-radioativo liofilizado e de multi-doses, processo para a preparação de múltiplas doses de paciente unitárias do radiofarmacêutico tetrofosmina ^ 99m^ tc, composição radiofarmacêutica estabilizada, e, dose de paciente unitária do radiofarmacêutico tetrofosmina ^ 99m^tc a presente invenção refere-se a composições radiofarmaeêuticas ^ 99m^tce estabilizadas da tetrofosmina de ligando, que incluem um ácido ascórbico ou radioprotetor de ascorbato, na ausência de um conservante antimicrobiano. a invenção também fornece kits liofilizados, adequados para a preparação em massa de múltiplas doses unitárias de paciente de complexos metálicos de ^ 99m^ tc-tetrofosmina. são também descritas doses unitárias de ^ 99m^tc-teftofosmina, junto com processos para preparar tais doses unitárias do frasco de massa liofihizada.
BRPI0518636A 2004-12-15 2005-10-14 “kits não-radioativo liofilizado de multi-doses, e, processo para a preparação de múltiplas doses de paciente unitárias do radiofarmacêutico tetrofosmina- 99m tc" BRPI0518636B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0427392.6A GB0427392D0 (en) 2004-12-15 2004-12-15 Stabilised 99mTc compositions
PCT/GB2005/003975 WO2006064175A1 (en) 2004-12-15 2005-10-14 STABILISED 99mTC COMPOSITIONS

Publications (3)

Publication Number Publication Date
BRPI0518636A2 BRPI0518636A2 (pt) 2008-12-02
BRPI0518636B1 BRPI0518636B1 (pt) 2016-12-13
BRPI0518636B8 true BRPI0518636B8 (pt) 2021-07-27

Family

ID=34090037

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518636A BRPI0518636B8 (pt) 2004-12-15 2005-10-14 “kits não-radioativo liofilizado de multi-doses, e, processo para a preparação de múltiplas doses de paciente unitárias do radiofarmacêutico tetrofosmina- 99m tc"

Country Status (17)

Country Link
US (1) US9694092B2 (pt)
EP (1) EP1824525B1 (pt)
JP (1) JP5064236B2 (pt)
KR (1) KR101297523B1 (pt)
CN (2) CN103028123A (pt)
AT (1) ATE392218T1 (pt)
AU (1) AU2005315503B2 (pt)
BR (1) BRPI0518636B8 (pt)
CA (1) CA2590620C (pt)
DE (1) DE602005006157T2 (pt)
ES (1) ES2306219T3 (pt)
GB (1) GB0427392D0 (pt)
MX (1) MX2007007223A (pt)
NO (1) NO340538B1 (pt)
PL (1) PL1824525T3 (pt)
RU (1) RU2403067C2 (pt)
WO (1) WO2006064175A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029178B1 (en) * 2006-06-21 2012-03-14 GE Healthcare Limited Radiopharmaceutical products
EP2080526A4 (en) * 2006-11-09 2012-11-07 Nihon Mediphysics Co Ltd RADIOACTIVE DIAGNOSTIC IMAGING AGENT
GB0718386D0 (en) 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
RU2463075C1 (ru) * 2011-07-01 2012-10-10 Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации СПОСОБ ПОЛУЧЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ-99m НАНОКОЛЛОИДА
RU2512595C1 (ru) * 2013-01-09 2014-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ онкологии" СО РАМН) СПОСОБ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ ПРИГОТОВЛЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ 99-m НАНОКОЛЛОИДА НА ОСНОВЕ ГАММА-ОКСИДА АЛЮМИНИЯ
RU2543654C1 (ru) * 2013-11-29 2015-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" СПОСОБ ПОЛУЧЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ-99m НАНОКОЛЛОИДА
EP2899195A1 (en) 2014-01-28 2015-07-29 ROTOP Pharmaka AG Stabilized form of Tetrofosmin and its use
EP3183009B1 (en) * 2015-09-30 2023-08-09 Duke University Contrast agents for magnetic resonance imaging
IT201600101875A1 (it) * 2016-10-11 2018-04-11 Advanced Accelerator Applications Int S A Composizioni liofilizzate comprendenti rhAnnexin V-128, processo per la loro preparazione e loro uso per la preparazione di formulazioni contenenti 99mTc-rhAnnexin V-128
CO2018001307A2 (es) 2017-03-08 2018-09-20 Jubilant Generics Ltd Formerly A Division Of Jubilant Life Sciences Ltd Un proceso mejorado para la preparación de tetrofosmina o su sal de adición de ácido
US11857647B2 (en) * 2017-11-23 2024-01-02 Jubilant Draximage, Inc. Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof
AU2019337115B2 (en) * 2018-10-06 2022-03-03 Jubilant Generics Limited Pharmaceutical compositions of sulfur colloid and processes thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761944B (en) 1975-04-30 1977-03-30 Procter & Gamble Stable radiographic scanning agents
JPS5750928A (en) * 1980-09-13 1982-03-25 Nippon Mejifuijitsukusu Kk Diagnostic agent for scanning bone
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
GB8808414D0 (en) * 1988-04-11 1988-05-11 Amersham Int Plc Ligands & cationic complexes thereof with technetium-99m
JP2860157B2 (ja) 1990-10-31 1999-02-24 日本メジフィジックス株式会社 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US5300280A (en) * 1992-02-14 1994-04-05 Mallinckrodt Medical, Inc. Stabilized radiopharmaceutical kits
DE60036382D1 (de) * 1999-06-21 2007-10-25 Nihon Mediphysics Co Ltd Verfahren zur verabreichung von arzneimitteln mit bindungsaffinität zum plasmaprotein und verwendung der zusammensetzung in dem verfahren
CN1184225C (zh) * 2000-06-28 2005-01-12 北京师范大学 一种替曲膦季鏻盐及其制法和二步法替曲膦药盒及其应用
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
MXPA03007595A (es) * 2001-02-26 2003-12-04 Bristol Myers Squibb Pharma Co Analogos de acido ascorbico para metalorradiofarmaceuticos.

Also Published As

Publication number Publication date
ATE392218T1 (de) 2008-05-15
MX2007007223A (es) 2007-08-14
WO2006064175A1 (en) 2006-06-22
JP5064236B2 (ja) 2012-10-31
CN101107017A (zh) 2008-01-16
BRPI0518636A2 (pt) 2008-12-02
JP2008524178A (ja) 2008-07-10
US20110008252A9 (en) 2011-01-13
AU2005315503B2 (en) 2011-06-02
DE602005006157T2 (de) 2009-05-28
KR101297523B1 (ko) 2013-08-16
CN103028123A (zh) 2013-04-10
KR20070089156A (ko) 2007-08-30
US9694092B2 (en) 2017-07-04
NO340538B1 (no) 2017-05-02
AU2005315503A1 (en) 2006-06-22
ES2306219T3 (es) 2008-11-01
RU2007120467A (ru) 2009-01-27
RU2403067C2 (ru) 2010-11-10
CA2590620A1 (en) 2006-06-22
EP1824525B1 (en) 2008-04-16
BRPI0518636B1 (pt) 2016-12-13
GB0427392D0 (en) 2005-01-19
EP1824525A1 (en) 2007-08-29
US20090311178A1 (en) 2009-12-17
DE602005006157D1 (de) 2008-05-29
CA2590620C (en) 2012-12-04
PL1824525T3 (pl) 2008-11-28
NO20073158L (no) 2007-07-04

Similar Documents

Publication Publication Date Title
BRPI0518636B8 (pt) “kits não-radioativo liofilizado de multi-doses, e, processo para a preparação de múltiplas doses de paciente unitárias do radiofarmacêutico tetrofosmina- 99m tc"
IL247486B (en) A composition comprising nanoparticles comprising docetaxel, albumin and citrate, uses thereof, a method for it's preparation and a sealed vial and a kit comprising the composition
WO2007042781A3 (en) Automated method for preparing technetium complexes
TNSN07341A1 (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
BRPI0507684B8 (pt) agentes de contraste para imagem de perfusão miocárdica
IL181529A (en) A method for radiofluorination, a compound containing radioactive fluorine and its use in the preparation of a radioactive drug
BR0210965A (pt) Conjugado de quelador, complexo de radiometal, radiofármaco, kit para a preparação do mesmo, composto, e, processo para a preparação do mesmo
BG108497A (en) Solid-phase nucleophilic fluorination
WO2006012527A8 (en) Bivalent linkers and conjugates thereof
WO2002062398A3 (en) Radioactively labelled conjugates of phosphonates
WO2007016352A3 (en) Oral liquid losartan compositions
GB0520529D0 (en) Automated radiolabelling method
BRPI0313764A2 (pt) método de preparação de composições de inalação de pó seco
WO2007008232A3 (en) Locoregional internal radionuclide ablation of abnormal tissues.
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
WO2009013358A3 (en) Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions
WO2005084168A3 (en) MINIATURIZED 62Zn/62Cu GENERATOR FOR HIGH CONCENTRATION CLINICAL DELIVERY OF 62Cu KIT FORMULATION FOR THE FACILE PREPARATION OF RADIOLABELED Cu-BIS(THIOSEMICARBAZONE) COMPOUNDS
WO2006037988A3 (en) Novel technetium and rhenium complexes, ligands used in their preparation and their use as radiopharmaceuticals
ATE287716T1 (de) Metallsalze als antimykotika
MX2007010361A (es) Sales de fosfato de los compuestos de 6-dimetilaminometil-1(3-meto xifenil)-1, 3-dihidroxi-ciclohexano.
ATE454144T1 (de) Behandlung von malignen neoplasien
Campbell Industrial participitation brings benefits to South African defence industry. A status report.
Gniazdowska et al. Labelling of vasopressin by mixed''4+ 1 ligands''technetium-99m complexes; Znakowanie wazopresyny mieszanymi kompleksami Tc-99m''typu 4+ 1''
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
TH116664A (th) สารประกอบเชิงซ้อนเหล็ก-คาร์โบไฮเดรต

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/12/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/10/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2692 DE 09-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.